- Home
- VSTM vs MLAC Comparison
VSTM vs MLAC Comparison
Compare VSTM & MLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- MLAC
- Stock Information
- Founded
- VSTM 2010
- MLAC 2024
- Country
- VSTM United States
- MLAC United States
- Employees
- VSTM N/A
- MLAC N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- MLAC
- Sector
- VSTM Health Care
- MLAC
- Exchange
- VSTM Nasdaq
- MLAC NYSE
- Market Cap
- VSTM 359.9M
- MLAC 314.4M
- IPO Year
- VSTM 2012
- MLAC 2024
- Fundamental
- Price
- VSTM $7.17
- MLAC $10.18
- Analyst Decision
- VSTM Strong Buy
- MLAC
- Analyst Count
- VSTM 9
- MLAC 0
- Target Price
- VSTM $13.63
- MLAC N/A
- AVG Volume (30 Days)
- VSTM 1.4M
- MLAC 94.6K
- Earning Date
- VSTM 05-20-2025
- MLAC 01-01-0001
- Dividend Yield
- VSTM N/A
- MLAC N/A
- EPS Growth
- VSTM N/A
- MLAC N/A
- EPS
- VSTM N/A
- MLAC N/A
- Revenue
- VSTM $10,000,000.00
- MLAC N/A
- Revenue This Year
- VSTM $7.68
- MLAC N/A
- Revenue Next Year
- VSTM $605.06
- MLAC N/A
- P/E Ratio
- VSTM N/A
- MLAC $415.34
- Revenue Growth
- VSTM N/A
- MLAC N/A
- 52 Week Low
- VSTM $2.10
- MLAC $9.94
- 52 Week High
- VSTM $13.52
- MLAC $10.17
- Technical
- Relative Strength Index (RSI)
- VSTM 57.92
- MLAC N/A
- Support Level
- VSTM $6.35
- MLAC N/A
- Resistance Level
- VSTM $8.00
- MLAC N/A
- Average True Range (ATR)
- VSTM 0.67
- MLAC 0.00
- MACD
- VSTM 0.01
- MLAC 0.00
- Stochastic Oscillator
- VSTM 46.93
- MLAC 0.00
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About MLAC MOUNTAIN LAKE ACQUISITION CORP
Mountain Lake Acquisition Corp is a blank check company.